Tag: psychedelics

EXPLORING SEX AND PSYCHEDELICS

The connection between sex and psychedelics dates back to the sexual liberation movement throughout the 1960s and 70s. Psychedelics, in particular LSD, were associated with loosened sexual inhibitions and the resolution of past sexual trauma. Inspired by Timothy Leary’s infamous calls to ‘turn up, tune in, drop out’, psychedelics appeared as a tool for pleasure, love and self-expression. 

For sex guru Annie Sprinkle, using psychedelics through the 60s, 70s and 80s had profound positive impacts on her sex life. From opening doors to alternative realities, to increasing connectedness and sexual satisfaction between partners, Annie calls them her ‘greatest sexual educators’. 

She notes that the connection between sex and psychedelics is much deeper than arousal. Through each experience the user gains new information, allowing them to see themselves from a new perspective. This, in turn, can inform the individual’s sexual life.

Even though psychedelics remain illegal across much of the world, anecdotal evidence suggests that using psychedelics to enhance sexual experiences is still just as popular as it once was. However, as sex on drugs has inevitably been labelled a high-risk activity , there is a clear lack of hard-line statistics to back up such an assumption. 

Keep reading

Magic mushroom dispensaries multiplying in southwestern Ontario, with no cap in sight

Flying in the face of local law enforcement, a chain of illegal brick-and-mortar magic mushroom dispensaries with locations in London, Windsor, and across the province is expanding to more local municipalities, strengthening a trend reminiscent of the pre-legalization cannabis market.

A recently opened storefront in St. Thomas is the latest move for FunGuyz, the entity that runs at least 13 dispensaries in Canada and one in Detroit, with a spokesperson suggesting other nearby small towns may be next.

“We’re looking at Sarnia, Strathroy, smaller cities surrounding London,” said a spokesperson who identified themselves only as Edgar and said the St. Thomas store opened last week.

In the past, different spokespeople for the company have all identified themselves as Edgar, or Edgars Gorbans. When asked if the name was real by CBC Windsor in early August, one spokesperson claiming to be named Edgar Gorbans said  “could be,” and “of course not.”

The latest expansion comes despite recent police raids at FunGuyz stores. London Police raided the local store in early July, whereas Windsor Police have raided their local store multiple times, and issued an arrest warrant for the store’s owner, who they identified as Edward Gorbans. 

Keep reading

I Went to Rehab for Alcoholism 18 Times. Only Psychedelics Helped

I met Amanda at a pain therapy clinic in Zurich last December. She was sitting on a chair, hands folded neatly in her lap – she’d come here with her husband Tim for one of her regular visits to neurologist Livia Granata, one of the few specialists in Switzerland offering psychedelic therapy. 

British-born Amanda is 50 years old and has been an alcoholic for two decades. She also struggles with severe depression and anxiety stemming from childhood trauma. It took a lot for her to share her story, so she asked to be referred to on a first-name basis to protect her and her husband’s privacy. 

For the past seven years, Amanda hasn’t lived in her flat with her partner and their children, but outside on the balcony. She stays in an improvised shelter her husband made for her, only going in to use the toilet – and the pandemic only further tightened the grip her anxiety disorders have on her life.

A year ago, Amanda probably wouldn’t have shown up for this appointment at all, either cancelling at the last minute or simply letting it pass. Over the years, she’s been through too many treatments – experimental therapies that brought little to no relief. But in April 2022, she found her way to the clinic – and to the first treatment she felt ever truly worked.

Keep reading

“I’ve been here before”: DMT study explores a strange memory phenomenon

If you take a psychedelic drug that can throttle your conscious perception into an otherworldly space where people often report encountering beings that are unlike anything on Earth, the last thing you would expect to feel is the sense that this all seems pretty familiar. But that’s precisely what some people report after taking the world’s strongest psychedelic: DMT. 

“It felt like I had been reunited with everything, like I was complete again,” psychiatrist Dr. Chloe Sakal told Freethink in 2021 while describing a DMT experience she had as a participant in a study that examined the drug’s effects on the brain. “I no longer knew I was in an MRI scanner. My entire reality was very different — really colorful, really vibrant. And I couldn’t even remember that I was in a study. I was in a different dimension.”

Online reports from the r/DMT subreddit convey similarly intense and familiar experiences. “I was beyond time and matter and had no sense of identity whatsoever,” wrote one person. “I definitely felt this common thing like I was ‘at home,’ that I have already been there, and that I will go there again.”

Keep reading

The Return of MDMA

In 2006 a Florida man named Zulfi Riza reached out to Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS). Riza was suicidal. He was suffering from PTSD, anxiety, depression, and anger issues. He had tried countless remedies, and he felt that Doblin was his last hope. Riza had heard that an underground network of psychiatrists practiced therapy using the illegal drug MDMA, better known as ecstasy or molly. And Doblin knew of such a therapist.

But Riza also suffered seizures. Should a medical emergency take place during a session, the therapist would be exposed and could lose their license, or worse.

Doblin told him he couldn’t help. Riza killed himself the very same morning.

The Drug Enforcement Administration (DEA) had unilaterally outlawed MDMA in 1985 under emergency powers granted to it by Congress. To back up the ban, the agency cited flimsy evidence about MDA, another drug entirely. It was a catastrophic case of government overreach. Zulfi Riza was just one of many people whose lives may have been saved had they not been forced to seek help in secret.

The DEA isn’t the only villain in this story. In 2002, a senator from Delaware named Joe Biden proposed the Reducing Americans’ Vulnerability to Ecstasy (RAVE) Act. This eventually passed, in somewhat watered-down form, as the Illicit Drug Anti-Proliferation Act. It basically made party organizers liable for drugs consumed on the premises. This made it much more complicated to organize services such as testing partygoers’ drugs for dangerous ingredients, as it would implicitly admit there was drug-taking on-site.

At a time when Americans are dying in record numbers from accidentally ingesting substances such as fentanyl, a de facto ban on drug checking in places where Americans take drugs—clubs, festivals—seems especially criminal.

Now that the war on weed is all but lost—federal legalization of marijuana feels like a matter of when, not if—the next battlefront will be over MDMA and other psychedelics. This year Australia allowed licensed therapists to give patients the drug. (It did the same as well for magic mushrooms.) Meanwhile, the Biden administration expects MDMA and psilocybin to be approved therapeutically within the next few years.

Keep reading

Psychoactive drug Psilocybin being studied for treatment of anorexia

Just a single dose of psilocybin was safe and tolerable for adult women with anorexia, according to a phase I open-label feasibility study.

After receiving a 25-mg dose of synthetic psilocybin given with therapist-delivered psychological support, none of the 10 participants experienced any significant changes in vital signs, ECGs, or suicidality during the week after dosing, reported Stephanie Knatz Peck, PhD, of the University of California San Diego, and colleagues.

Meeting the primary outcome, the treatment was also well-tolerated, with no serious adverse events reported amongst participants, who had an average body mass index (BMI) of 19.7, they noted in Nature Medicine.

As for changes in psychopathology — the secondary outcome of the early-stage trial — concerns about weight significantly decreased from baseline to 1 month after psilocybin treatment.

This improvement was also maintained up to 3 months after dosing. Likewise, shape concerns significantly dropped within the month after treatment, but this change was no longer significant at the 3-month mark.

Changes in eating concerns and dietary restraint didn’t reach statistical significance, but there was a trend towards an improvement in eating concerns at the 3-month follow-up.

Keep reading

American Medical Association Promotes Psychedelics Research, Opposes Kratom Criminalization And Affirms Support For Marijuana Drug Testing

The American Medical Association (AMA) has adopted a series of new drug policy positions, including advocating for psychedelics research, opposing the criminalization of kratom, calling for an end to the sentencing disparity between crack and powder cocaine and supporting the continued inclusion of marijuana metabolites in employment-based drug tests.

The organization’s House of Delegates, which met last month to consider numerous resolutions, also declined to approve an additional measure to revise its stance on marijuana in a way that would have maintained its opposition to legalization while implicitly recognizing the benefits of regulating cannabis products—instead opting to continuing its advocacy for prohibition without the newly proposed regulatory language.

This comes about a year after AMA delegates voted to amend its policy position to support the expungement of past marijuana convictions in states that have legalized the plant.

At the most recent meeting, the body tackled several different areas of drug policy.

The American Kratom Association (AKA) cheered the adoption of a new resolution that says people “who are using kratom only for personal use should not face criminal consequences”—though the measure also says that the substance should be “evaluated by the relevant regulatory entities for its appropriateness for sale and potential oversight via the Controlled Substances Act, before it can be marketed, purchased, or prescribed.”

Keep reading

VA And Defense Department Oppose Medical Marijuana For PTSD, But Take Neutral Position On Psychedelics As Research Continues

The U.S. Department of Veterans Affairs (VA) and Department of Defense (DOD) are strongly against the use of marijuana for the treatment of post-traumatic stress disorder (PTSD)—but they’re taking a neutral position on psychedelics like psilocybin and LSD, simply saying that more research should be done.

In an update to their joint clinical practice guidelines, the departments provided recommendations on a variety of therapeutics used to treat PTSD and acute stress disorder that commonly afflict military veterans. And while many veterans use marijuana, often to treat symptoms of the conditions, the VA/DOD Management of Posttraumatic Stress Disorder and Acute Stress Disorder Work Group said it is fully against the alternative treatment option.

“The Work Group recommends against the use of cannabis or cannabis derivatives in treating patients with PTSD because of the lack of well-designed [randomized control trials] evaluating the efficacy of cannabis derivatives in large samples of individuals with PTSD and the serious side effects associated with their use,” it says.

“Evidence from the 2017 VA/DoD PTSD [clinical practice guidelines] indicates significant harm associated with cannabis use,” it said, arguing that research suggests that marijuana is linked to issues with attention, memory, IQ and driving.

While medical marijuana came with a “strong against” recommendation from the departments, they said that the work group’s confidence in the existing evidence is “very low” due to a “lack of randomized, controlled, methodologically sound clinical trials; small sample sizes, and selection bias.”

“The benefits of cannabis were outweighed by the potential serious adverse effects,” the document, published last month, says. “Patient values and preferences varied largely because some patients seek new, novel treatments although others might be unwilling to use cannabis or cannabis derivatives. Thus, the Work Group made the following recommendation: We recommend against cannabis or cannabis derivatives for the treatment of PTSD.”

Keep reading

Traumas of the War on Drugs: Bring Back the Pyschedelics

I am a survivor of domestic abuse. 

I haven’t written about this before. It’s not in my memoir Good Cop Bad War. But it occurs to me that I now have a duty to be publicly honest about this because it is becoming clearer that as a society we could deal with the causes and harms of domestic violence better. As a police officer, I knew so many—way too many—survivors who deserve the very best help that science can provide.

My relationship with my wife had its difficult moments right from the start. Sam, as I named her in my memoir, had a difficult childhood. This played out with a powerful temper with an attention-grabbing sense of drama. Later in our relationship, this turned into psychological abuse. 

Her father was someone who used alcohol very problematically. His descent into mental illness was plain to see. On a holiday with her whole family, he became abusive to everyone and this manifested itself in really dark ways. And he tried to start a fight with me, swaying, fists raised, calling me names. 

Growing up with addiction in the family can cause trauma in childhood. This is widely understood. As I got to know Sam and heard tales of her childhood, and teenage years, I instinctively understood the trauma. And as such I later understood the origins of her abuse towards me. 

Sam rarely physically assaulted me. And when she did it actually was a relief because I knew then that her temper would immediately subside and she would become apologetic and tearful; and I can take a few punches. The behavior that was my nightmare was when she deliberately stopped me sleeping. This became such an issue that my fear of it happening when I was working long hours at times dominated my thoughts. It was horrible. If I complained when she did it, she  would descend into the worst petty abuse. “Man up, Neil”. I was pathetic, worthless. 

I forgave her, of course I did. I loved her. But most importantly I understood where it was coming from. So, I empathized and treated her as gently as I could. Until I couldn’t anymore. 

As my years of undercover work went by, I was increasingly finding myself seeing  work as an escape from home. It was a relief for me but also being away seemed to take the pressure away from our relationship. Less time together seemed to translate to less abuse. 

I was unaware, however, that my mental health was declining. The beginnings of what would later become CPTSD (complex post-traumatic stress disorder) was changing me. I became emotionally numb, even while I kept going back to the dangerous work I was involved in. Feeling lost, I anesthetized  myself with alcohol, I had affairs. At home I no longer was able to find that gentle understanding. The empathy. I must have appeared colder and more distant. And so, the abuse increased and got worse. My descent into mental illness accelerated and it was an extraordinarily difficult time hiding what was going on from our children. 

In our divorce papers, Sam denied ever physically assaulting me. But she did formally admit to the intentional sleep deprivation. Interesting that the physical assault was a taboo too far for her. But the emotional abuse was something easier to admit. (We learn as children.) 

Keep reading